Methamphetamine (MA) use is a growing global crisis, second only to marijuana in terms of prevalence. This powerful stimulant poses severe health risks, with overdoses often proving fatal.
Harlequin ichthyosis, an extraordinarily rare autosomal recessive disorder affecting 1 in 3 million births, turns skin into thick, scaly armor. Preterm deliveries, early births, and consanguineous marriages heighten the risk.
In a groundbreaking surgical endeavor, doctors in Chennai, India, have successfully removed what is believed to be the world’s largest uterine tumor.
In the bustling city of Changchun, China, a 26-year-old woman presented with a perplexing medical conundrum. For five years, she had endured frequent urination, hematuria, and persistent abdominal pain.
In an unprecedented case, we report the only known instance of HTL linked to an indoor swimming pool, affecting five family members, including one non-resident.
In a recent report published in The New England Journal of Medicine, a peculiar and alarming case involving a 12-year-old boy with a bright yellow tongue has shed light on a rare disorder, captivating the medical community.
Spontaneous haemoperitoneum in pregnancy (SHiP) is a rare but life-threatening condition for both mother and baby. Though it can strike at any stage of pregnancy, it’s most commonly seen in the third trimester.
Baboon syndrome, also known as symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), is a striking erythematous maculopapular rash that appears symmetrically in skin folds.
In a story that sounds like it’s straight out of a medical thriller, a rare condition known as lithopedion has come into the spotlight, reminding the medical community of the extraordinary ways the human body can adapt to unexpected situations.
Nearly thirty years ago, a 14-year-old girl in the United Kingdom was hit in the eye by a shuttlecock during a game of badminton. In the aftermath, she lost her hard contact lens—a small inconvenience that didn’t warrant much concern.
This Privacy Notice shall be read in conjunction with the Privacy Policy to the extent this Notice does not mention or specify the particulars that should have been mentioned or specified relating to the Notice in pursuance of the provisions of the Data Protection Laws as applicable.
On having accessed or visited this Platform you the Noticee hereby voluntarily consent to and take notice of the fact that the personal data, by which or in relation whereto you the concerned Noticee is identifiable, shall be retained, stored, used, and may be processed by the Company for the purpose and in the manner, though legal, found suitable to it for commercial and/or some other reasons. The detailed specificity whereof may be found in the Privacy Policy. The consent provided herein may be withdrawn anytime by you, the Noticee, at its own volition by removing your profile or by writing to us at support@docquity.com.
As a Noticee, you shall have the right to grievance redressal, in relation to your consent or our use of your personal data, which you may address by writing to us at dpo@docquity.com. Should you, the Noticee, thereafter remain unsatisfied or dissatisfied with the resolution provided by us, you, the Noticee, may approach the concerned regulatory authority for the redressal of your grievance.
By using this platform, you consent to our use of your personal data as detailed in our Privacy Policy, and acknowledge that we use cookies to improve your browsing experience
